Institutional investors purchased a net $2.2 million shares of INVA during the quarter ended March 2018. This may signal that the smart money is gaining interest in this company as the 73.95% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
RENAISSANCE TECHNOLOGIES LLC Bought 786.9 Thousand shares of Innoviva Inc
NUMERIC INVESTORS LLC Bought 540.7 Thousand shares of Innoviva Inc
UBS SECURITIES LLC Bought 525.5 Thousand shares of Innoviva Inc